Lacasse P, Petitclerc D, Pelletier G, Delorme L, Morisset J, Gaudreau P, Brazeau P
Sherbrooke University, Quebec.
Domest Anim Endocrinol. 1991 Jan;8(1):99-108. doi: 10.1016/0739-7240(91)90044-k.
Fifteen cows (87 +/- 8 d in lactation; 641 +/- 33 kg BW) were randomly assigned to treatment and then subjected for 182 d to daily sc injection (1000 hr), in the cervical area, of saline (control), thyrotropin-releasing factor (TRF: 1 micrograms/kg BW), growth hormone-releasing factor (1-29)NH2 (GRF; 10 micrograms/kg BW) or GRF plus TRF (10 and 1 micrograms/kg BW, respectively) according to a 2 x 2 factorial design. On days 1, 31, 88 and 179, jugular blood samples were collected from 2 hr before to 6 hr after injection. Samples were also collected for 5 consecutive days after cessation of treatment. GRF always induced growth hormone (GH) release (600 vs 7925 ng.min/ml) with augmentation of response with time (interaction GRF * day; P less than .001). TRF did not affect (P greater than .25) GH release; there was no interaction (P greater than .25) with time. There was no significant interaction (P greater than .25) between GRF and TRF on GH release. However, the amount of GH release with GRF plus TRF was always greater than with GRF alone (9419 vs 6431 ng.min/ml). TRF induced a significant release of prolactin (23769 vs 42175 ng.min/ml) but GRF reduced the amount of prolactin release on the last day of sampling. TRF induced thyroid stimulating hormone (TSH) release only on the first day of injection while triiodothyronine (T3) and thyroxine (T4) continued to respond to TRF throughout the treatment period. Concentrations of T3 and T4 fell below control levels after cessation of TRF injection. In conclusion, GRF-induced GH release and TRF-induced Prl and thyroid hormone release were maintained over a 6-mo treatment period. TRF induced TSH release only on the first day of injection. Overall, these results raised the possibility of a direct effect of TRF on the thyroid gland.
15头奶牛(泌乳期87±8天;体重641±33千克)被随机分配到各处理组,然后按照2×2析因设计,在颈部区域每日皮下注射(1000时)生理盐水(对照组)、促甲状腺素释放因子(TRF:1微克/千克体重)、生长激素释放因子(1-29)NH2(GRF;10微克/千克体重)或GRF加TRF(分别为10和1微克/千克体重),持续182天。在第1、31、88和179天,在注射前2小时至注射后6小时采集颈静脉血样。在停止治疗后还连续5天采集样本。GRF总是能诱导生长激素(GH)释放(600对7925纳克·分钟/毫升),且随着时间推移反应增强(GRF*天数交互作用;P<0.001)。TRF对GH释放无影响(P>0.25);与时间无交互作用(P>0.25)。GRF和TRF对GH释放无显著交互作用(P>0.25)。然而,GRF加TRF时的GH释放量总是大于单独使用GRF时(9419对6431纳克·分钟/毫升)。TRF能诱导催乳素显著释放(23769对42175纳克·分钟/毫升),但GRF在采样最后一天减少了催乳素释放量。TRF仅在注射第一天诱导促甲状腺激素(TSH)释放,而在整个治疗期间三碘甲状腺原氨酸(T3)和甲状腺素(T4)持续对TRF有反应。停止注射TRF后,T3和T4浓度降至对照水平以下。总之,在6个月的治疗期内,GRF诱导的GH释放以及TRF诱导的PRL和甲状腺激素释放得以维持。TRF仅在注射第一天诱导TSH释放。总体而言,这些结果增加了TRF对甲状腺有直接作用的可能性。